Home/Investors/Sanofi Ventures

Sanofi Ventures

Biotech Investor · 9 portfolio companies

Portfolio

9

Focus Areas

16

Top Stage

Phase 1

Investment Focus

Neuroscience Immunology Autoimmune Diseases Ophthalmology Retinal Diseases Neurodegenerative Diseases Autoimmune Disorders Inflammatory Disorders Inflammation Autoimmunity Fibrosis Alzheimer's Disease Neuropsychiatry Major Depressive Disorder Oncology

Portfolio Companies

Company	Stage	Valuation	Focus
Arialys Therapeutics	phase-1	—	Neuroscience, Immunology
Character Biosciences	Phase 1	—	Ophthalmology, Retinal Diseases
Lifordi Immunotherapeutics	Phase 1	—	Autoimmune Disorders, Inflammatory Disorders
Granite Bio	Phase 1	—	Inflammation, Autoimmunity
Korsana Biosciences	Pre-clinical	—	Neurodegenerative Diseases, Alzheimer's Disease
Draig Therapeutics	Phase 2	—	Neuropsychiatry, Major Depressive Disorder
Nucleai	—	—	Oncology
SpliceBio	Phase 1	—	Ophthalmology, Genetic Diseases
QuantX Biosciences	Pre-clinical	—	Immunology, Inflammation

Frequent Co-Investors

Access Biotechnology2 shared Novartis Venture Fund2 shared OrbiMed1 shared 5AM Ventures1 shared Atlas Venture1 shared Versant Ventures1 shared ARCH Venture Partners1 shared Venrock1 shared